Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Management of Helicobacter pylori-related disorders.

European journal of gastroenterology & hepatology·2012
Same author

Hutchison's litany.

Journal of the Royal Society of Medicine·2010
Same author

Medical students and history of medicine.

Journal of the Royal Society of Medicine·2010
Same author

Admission of a patient to hospital on a stretcher.

Journal of the Royal Society of Medicine·2010
Same author

Disorders of colonic motility.

Proceedings of the Royal Society of Medicine·2010
Same author

Rising trends of gastric cancer and peptic ulcer in the 19th century.

Alimentary pharmacology & therapeutics·2010

相关实验视频

Updated: Jul 11, 2026

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
10:44

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

一周的根除治疗方案用于Helicobacter pylori.

R P Logan1, P A Gummett, J J Misiewicz

  • 1Parkside Helicobacter Study Group, Central Middlesex Hospital, London, UK.

Lancet (London, England)
|November 16, 1991
PubMed
概括

短暂的七天治疗,将三二二甲酸盐和阿莫西西林与美特罗尼达结合在一起,在72%的患者中有效消灭了Helicobacter pylori. 这种疗法是安全的,耐受性很好,对于对美特龙醇敏感的H.pylori感染特别有效.

科学领域:

  • 胃肠病学 胃肠病学
  • 传染性疾病 传染性疾病
  • 药理学 药理学 是一个学科.

背景情况:

  • 杆菌感染是胃炎和十二指肠复发的常见原因.
  • 目前针对H. pylori根除的现有治疗方案缺乏完全的安全性和有效性.

研究的目的:

  • 评估H. pylori感染的短期根除方案的疗效和安全性.
  • 评估对甲尼达耐药性对治疗结果的影响.

主要方法:

  • 一种为期七天的治疗方案,包括三二二甲酸盐,阿莫西西林和美特罗尼达给了106名感染H. pylori的患者.
  • 患者有胃潰瘍或非潰瘍性消化不良.
  • 对H. pylori的根除率和副作用进行了监测;对甲尼达的敏感性进行了评估.

主要成果:

  • 在76/106名 (72%) 患者中成功根除了H. pylori.
  • 与耐药菌株患者相比,对美特龙醇敏感的H. pylori患者的根除率 (93%) 显著高于耐药菌株患者.
  • 报告了轻微的副作用,最常见的是味觉障碍.

结论:

  • 一周的根除疗法是H. pylori的安全,有效和耐受良好的治疗选择.

更多相关视频

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
06:40

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance

Published on: July 28, 2023

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

相关实验视频

Last Updated: Jul 11, 2026

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
10:44

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
06:40

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance

Published on: July 28, 2023

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

  • 甲尼达的敏感性是这一疗法的成功的一个关键因素.
  • 这种治疗为对美特龙醇敏感的H.pylori感染提供了具有成本效益的方法.